✦ LIBER ✦

Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients

✍ Scribed by Kerry D Solomon; Eric D Donnenfeld; Michael Raizman; Helga P Sandoval; Katherine Stern; Amanda VanDenburgh; Janet K Cheetham; Rhett Schiffman

Book ID: 116625398
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 165 KB
Volume: 30
Category: Article
ISSN: 0886-3350
DOI: 10.1016/j.jcrs.2004.05.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analgesic efficacy and safety of nonpres

Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy

✍ Richard W. Yee 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 979 KB

Efficacy and safety of ketorolac trometh

Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis

✍ Peter C. Donshik; David Pearlman; Jacob Pinnas; Michael B. Raizman; Joseph Taube 📂 Article 📅 2000 🏛 Springer Healthcare Communications 🌐 English ⚖ 144 KB

Efficacy and safety profile of ketorolac

Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery

✍ Robert Stewart; Robert Grosserode; Janet K. Cheetham; Allan Rosenthal 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Efficacy and safety of 0.5% levofloxacin

Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients

✍ S.J. Lichtenstein; M. Rinehart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Efficacy and safety of 0.5% levofloxacin

Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients

✍ Steven J Lichtenstein; Mike Rinehart 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Ocular hypotensive efficacy and safety o

Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension*

✍ Franks, Wendy 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 326 KB